Xanthogranulomatous Pyelonephritis 

  • Author: Samuel G Deem, DO; Chief Editor: Bradley Fields Schwartz, DO, FACS   more...
 
Updated: Feb 27, 2012
 

Background

Xanthogranulomatous pyelonephritis (XGP), first described by Schlagenhaufer in 1916,[1] is a rare, serious, chronic inflammatory disorder of the kidney characterized by a destructive mass that invades the renal parenchyma. XGP is most commonly associated with Proteus or Escherichia coli infection. Pseudomonas species have also been implicated. The kidney is usually nonfunctional. Most cases of XGP involve a diffuse process; however, up to 20% are focal. (See Etiology and Pathophysiology.)

Pathologically, XGP is characterized by lipid-laden foamy macrophages. XGP shares many characteristics with true renal neoplasms in terms of its radiographic appearance and its ability to involve adjacent structures or organs. XGP is often associated with urinary tract obstruction, infection, nephrolithiasis, diabetes, and/or immunocompromise. (See Workup.)

The treatment of XGP is almost universally extirpative and can pose a formidable challenge to the surgeon. Although open extirpative therapy has historically been the hallmark of management, an increasing number of reports have described successful laparoscopic intervention. (See Treatment.)

Most cases of XGP are unilateral, but bilateral disease has been reported. Bilateral nephrectomy and long-term dialysis is a treatment option in such cases. Although Perez et al described successful treatment with partial nephrectomies in 1 patient,[2] bilateral XGP is usually fatal. (See Treatment.)

The overall prognosis for XGP is good. Death from this entity is exceedingly rare, although morbidity is substantial.

Epidemiology

XGP occurs in approximately 1% of all renal infections. It is 4 times more common in women than in men and is usually noted in the fifth and sixth decades of life. XGP affects both kidneys with equal frequency. Although XGP is rare in the pediatric population, it is found in approximately 16% of pediatric nephrectomy specimens. In children, XGP is more common in boys and usually affects those younger than 8 years.

Next

Anatomy

The kidneys are paired organs in the retroperitoneum. They are covered in a thin, fibrous capsule that is in turn covered by Gerota’s fascia. On the right, the liver and adrenal gland abut the superior pole of the kidney. The second part of the duodenum is medial to the right kidney and may be reflected medially to gain exposure to the inferior vena cava (Kocher maneuver). On the left, the superior pole of the kidney is attached to the spleen superolaterally (splenorenal ligament) and is very near to or in direct contact with the tail of the pancreas medially.

The colon is anterior to the kidneys and is easily reflected anteriorly and medially when transabdominal exposure is required. The renal hilar structure, from anterior to posterior, includes the vein, the artery, and the collecting system. The left renal vein has 3 draining tributaries—namely, the adrenal, gonadal, and posterior lumbar veins.

Previous
Next

Etiology and Pathophysiology

The exact etiology of xanthogranulomatous pyelonephritis (XGP) is unknown, but it is generally accepted that the disease process requires long-term renal obstruction and infection. As previously stated, XGP is most commonly associated with Proteus or Escherichia coli infection; Pseudomonas species have also been implicated.[3]

Stones (frequently of staghorn proportions) develop in 80% of patients with XGP but are not required to make the diagnosis. XGP is often observed in patients with diabetes, immunocompromise or both. Abnormal lipid metabolism has also been hypothesized as an etiologic factor in individuals with XGP.

XGP displays neoplasmlike properties capable of local tissue invasion and destruction and has been referred to as a pseudotumor. Adjacent organs, including the spleen, pancreas, or duodenum, may be involved. Malek and Elder have proposed the following stages of XGP involvement[4] :

  • Kidney
  • Perinephric fat
  • Adjacent retroperitoneal structures

The gross appearance of XGP is that of a mass of yellow tissue with regional necrosis and hemorrhage, superficially resembling renal cell carcinoma. The pathognomonic microscopic feature is the lipid-laden foamy macrophage accompanied by both chronic- and acute-phase inflammatory cells. Focal abscesses may be observed.

The primary mechanisms involved in XGP include nephrolithiasis, collecting system obstruction, and infection. No single factor can explain the process; rather, an inadequate host response to the acute inflammatory response occurs in the obstructed, necrotic kidney.[5]

Previous
 
 
Contributor Information and Disclosures
Author

Samuel G Deem, DO  Faculty in Urology, Institutional Scientific Review Board, Charleston Area Medical Center

Samuel G Deem, DO is a member of the following medical societies: American College of Osteopathic Surgeons, American College of Surgeons, American Osteopathic Association, American Society of Clinical Oncology, American Urological Association, Endourological Society, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Coauthor(s)

Joe D Mobley III, MD, MPH  Fellow, Department of Female Urology and Voiding Dysfunction, Cleveland Clinic Florida

Joe D Mobley III, MD, MPH is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Endourological Society, and Tennessee Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Additional Contributors

Gamal Mostafa Ghoniem, MD, FACS Professor of Urology, Chief, Division of Female Urology, Pelvic Reconstructive Surgery, and Voiding Dysfunction, Department of Urology, University of California, Irvine, School of Medicine

Gamal Mostafa Ghoniem, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urogynecologic Society, American Urological Association, International Continence Society, International Urogynaecology Association, and Society of Urodynamics and Female Urology

Disclosure: Astellas Honoraria Speaking and teaching; Coloplasty Consulting fee Board membership; Uroplasty Consulting fee Consulting

Scott Rutchik, MD Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine

Scott Rutchik, MD is a member of the following medical societies: American Urological Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Schlagenhaufer F. Uber eigentumlich staphylomykosender neiven und des pararenalen bindegewebes. Frankfurt Z Pathol. 1916;19:139-48.

  2. Peréz LM, Thrasher JB, Anderson EE. Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. J Urol. Jan 1993;149(1):100-2. [Medline].

  3. Kuo CC, Wu CF, Huang CC, et al. Xanthogranulomatous pyelonephritis: critical analysis of 30 patients. Int Urol Nephrol. Mar 2011;43(1):15-22. [Medline].

  4. Malek RS, Elder JS. Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol. May 1978;119(5):589-93. [Medline].

  5. Gregg CR, Rogers TE, Munford RS. Xanthogranulomatous pyelonephritis. Curr Clin Top Infect Dis. 1999;19:287-304.

  6. Hitti W, Drachenberg C, Cooper M, et al. Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature. Nephrol Dial Transplant. Nov 2007;22(11):3344-7. [Medline].

  7. Loffroy R, Guiu B, Varbédian O, Michel F, Sagot P, Cercueil JP, et al. Diffuse xanthogranulomatous pyelonephritis with psoas abscess in a pregnant woman. Can J Urol. Apr 2007;14(2):3507-9. [Medline].

  8. Tiguert R, Gheiler EL, Yousif R, et al. Focal xanthogranulomatous pyelonephritis presenting as a renal tumor with vena caval thrombus. J Urol. Jul 1998;160(1):117-8. [Medline].

  9. Shah HN, Jain P, Chibber PJ. Renal tuberculosis simulating xanthogranulomatous pyelonephritis with contagious hepatic involvement. Int J Urol. Jan 2006;13(1):67-8. [Medline].

  10. Rajesh A, Jakanani G, Mayer N, et al. Computed tomography findings in xanthogranulomatous pyelonephritis. J Clin Imaging Sci. 2011;1:45. [Medline]. [Full Text].

  11. Osca JM, Peiro MJ, Rodrigo M, Martinez-Jabaloyas JM, Jimenez-Cruz JF. Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment. Eur Urol. 1997;32(3):375-9. [Medline].

  12. Bercowsky E, Shalhav AL, Portis A, Elbahnasy AM, McDougall EM, Clayman RV. Is the laparoscopic approach justified in patients with xanthogranulomatous pyelonephritis?. Urology. Sep 1999;54(3):437-42; discussion 442-3. [Medline].

  13. Mahesan N, Choudhury SM, Khan MS, et al. One hand is better than two: conversion from pure laparoscopic to the hand-assisted approach during difficult nephrectomy. Ann R Coll Surg Engl. Apr 2011;93(3):229-31. [Medline].

  14. American Urological Association. Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis. Available at http://www.auanet.org/content/media/antimicroprop08.pdf.

Previous
Next
 
Xanthogranulomatous pyelonephritis.
Xanthogranulomatous pyelonephritis with obstruction and staghorn calculus.
Xanthogranulomatous pyelonephritis appearing as nonenhancing, low-attenuation areas of the dilated collecting system surrounded by enhancing, high-attenuation parenchyma (known as the "bear paw" sign).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.